IPAMORELIN PEPTIDE 2MG VIAL

Ipamorelin Peptide

Ipamorelin is a peptide that is 5 amino acids in length, comprised of both proteinogenic and non-proteinogenic amino acids in this sequence: Aib-His-D-2-Nal-D-Phe-Lys-NH₂

View Peptide Purity Reference Chart

*The information herein is for educational and informational purposes only. THIS PRODUCT IS FOR RESEARCH USE ONLY. For use in animal studies, all research must be conducted with oversight from the appropriate Institutional Animal Care and Use Committee (IACUC) following the guidelines of the Animal Welfare Act (AWA).

Storage: Lyophilized peptide should be stored at -20°C (freezer), and the reconstituted peptide solution at 4°C (refrigerated). Do not freeze once reconstituted.

[1] K. Raun et al., “Ipamorelin, the first selective growth hormone secretagogue,” Eur. J. Endocrinol., vol. 139, no. 5, pp. 552–561, Nov. 1998.

[2] “Helsinn Healthcare SA Announces the Acquisition of Sapphire Therapeutics, Inc. to Establish Helsinn Therapeutics (US) Inc. | BioSpace.” [Online]. Available: https://www.biospace.com/article/releases/helsinn-healthcare-sa-announces-the-acquisition-of-sapphire-therapeutics-inc-to-establish-helsinn-therapeutics-us-inc-/. [Accessed: 06-Oct-2019].

[3] J. V. S. Gobburu, H. Agersø, W. J. Jusko, and L. Ynddal, “Pharmacokinetic-Pharmacodynamic Modeling of Ipamorelin, a Growth Hormone Releasing Peptide, in Human Volunteers,” Pharm. Res., vol. 16, no. 9, pp. 1412–1416, 1999.

[4] Sociedad Anatómica Española, European journal of anatomy : official journal of the Spanish Society of Anatomy. Spanish Society of Anatomy.

[5] P. B. Johansen et al., “Ipamorelin, a new growth-hormone-releasing peptide, induces longitudinal bone growth in rats,” Growth Horm. IGF Res., vol. 9, no. 2, pp. 106–113, May 1999.

[6] J. Svensson et al., “The GH secretagogues ipamorelin and GH-releasing peptide-6 increase bone mineral content in adult female rats,” J. Endocrinol., vol. 165, no. 3, pp. 569–577, Jun. 2000.

[7] L. D. Baker et al., “Effects of Growth Hormone–Releasing Hormone on Cognitive Function in Adults With Mild Cognitive Impairment and Healthy Older Adults,” Arch. Neurol., vol. 69, no. 11, p. 1420, Nov. 2012.

[8] S. D. Friedman et al., “Growth Hormone–Releasing Hormone Effects on Brain γ-Aminobutyric Acid Levels in Mild Cognitive Impairment and Healthy Aging,” JAMA Neurol., vol. 70, no. 7, p. 883, Jul. 2013.

[9] M. V. Vitiello, K. E. Moe, G. R. Merriam, G. Mazzoni, D. H. Buchner, and R. S. Schwartz, “Growth hormone releasing hormone improves the cognition of healthy older adults,” Neurobiol. Aging, vol. 27, no. 2, pp. 318–323, Feb. 2006.

[10] P. B. JOHANSEN, K. T. Hansen, J. V Andersen, and N. L. Johansen, “Pharmacokinetic evaluation of ipamorelin and other peptidyl growth hormone secretagogues with emphasis on nasal absorption,” Xenobiotica, vol. 28, no. 11, pp. 1083–1092, Jan. 1998.